Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOPROSTENOL vs EPTINEZUMAB-JJMR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPOPROSTENOL vs EPTINEZUMAB-JJMR: Safety Overview

Metric EPOPROSTENOL EPTINEZUMAB-JJMR
Total FAERS Reports 13,322 7,165
Deaths Reported 2,713 42
Death Rate 20.4% 0.6%
Hospitalizations 8,838 438
Average Patient Age 49.9 yrs 50.0 yrs
% Female Patients 78.1% 85.5%
FDA Approval Date Apr 23, 2008 N/A
Manufacturer Mylan Institutional LLC N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription